Measuring apathy in Alzheimer’s disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): a comparison of instruments

BACKGROUND: Diagnostic criteria for apathy have been published but have yet to be evaluated in the context of clinical trials. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) operationalized the diagnostic criteria for apathy (DCA) into a clinical-rated questionnaire informed by interviews...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Geriatr Psychiatry
Autors principals: Lanctôt, Krista L., Scherer, Roberta W., Li, Abby, Vieira, Danielle, Coulibaly, Hamadou, Rosenberg, Paul B., Herrmann, Nathan, Lerner, Alan J, Padala, Prasad R, Brawman-Mintzer, Olga, van Dyck, Chris H., Porsteinsson, Anton P., Craft, Suzanne, Levey, Allan, Burke, William J, Mintzer, Jacobo E.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704818/
https://ncbi.nlm.nih.gov/pubmed/32565008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2020.05.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars